Epigenetics in human disease and prospects for epigenetic therapy
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Epigenetic mechanisms, which involve DNA and histone modifications, result in the heritable silencing of genes without a change in their coding sequence. The study of human disease has focused on genetic mechanisms, but disruption of the balance of epigenetic networks can cause several major pathologies, including cancer, syndromes involving chromosomal instabilities, and mental retardation. The development of new diagnostic tools might reveal other diseases that are caused by epigenetic alterations. Great potential lies in the development of 'epigenetic therapies'--several inhibitors of enzymes controlling epigenetic modifications, specifically DNA methyltransferases and histone deacetylases, have shown promising anti-tumorigenic effects for some malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are three main types of epigenetic modifications: DNA methylation, histone modifications, and various RNA-mediated processes (39, 40).”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [39]
In the citing paper
“and represents a prominent candidate to be a marker of ROS-induced mutagenesis and tumorigenesis41.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [41]
In the citing paper
“Activation and/or aberrant expression of a gene can contribute to the development of endometriosis, cancers, or other abnormalities.22”
From Altered genome-wide methylation in endometriosis (2014) · cites this paper as [22]
In the citing paper
“Many reports have demonstrated that epigenetic alterations play important roles in driving cancer initiation and progression [123, 124].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [123]
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“On a more global level, the ICF (immunodeficiency, centromeric region instability and facial anomalies) syndrome is caused by mutations in the DNMT3b gene, which is an essential enzyme required for the establishment of DNA methylation pattern”
BackgroundThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Self-citationRett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Self-citationThe history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
Regulation of Heterochromatic Silencing and Histone H3 Lysine-9 Methylation by RNAi
Volpe, T. A., Kidner, C., Hall, I. M., Teng, G., Grewal, S. I. S., & Martienssen, R. A. (2002) · Science · doi:10.1126/science.1074973 · Cited by 2,055
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Holliday, R., & Pugh, J. E. (1975) · Science · doi:10.1126/science.187.4173.226 · Cited by 1,972
Cited by
Items 601–700 of 1,013
Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases
Mai, A., Rotili, D., Tarantino, D., Nebbioso, A., Castellano, S., Sbardella, G., Tini, M., & Altucci, L. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.097 · Cited by 88
Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia
Galm, O., Wilop, S., Lüders, C., Jost, E., Gehbauer, G., Herman, J. G., & Osieka, R. (2005) · Annals of Hematology · doi:10.1007/s00277-005-0005-0 · Cited by 82
Wang, J., Sasco, A. J., Fu, C., Xue, H., Guo, G., Hua, Z., Zhou, Q., Jiang, Q., & Xu, B. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0733 · Cited by 89
Rahmatpanah, F. B., Carstens, S. J., Guo, J., Sjahputera, O., Taylor, K. H., Duff, D. J., Shi, H., Davis, J. W., Hooshmand, S., Chitma-Matsiga, R., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404345 · Cited by 87
Molecular and cellular mechanisms of memory allocation in neuronetworks
Won, J., & Silva, A. J. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.08.017 · Cited by 82
Emerging role of epigenetics and miRNA in diabetic cardiomyopathy
Asrih, M., & Steffens, S. (2012) · Cardiovascular Pathology · doi:10.1016/j.carpath.2012.07.004 · Cited by 84
Guo, W., Zhu, L., Zhu, R., Chen, Q., Wang, Q., & Chen, J. (2019) · eLife · doi:10.7554/elife.44310 · Cited by 87
Chan, C., Fang, C., Qiao, Y., Yarilina, A., Prinjha, R. K., & Ivashkiv, L. B. (2014) · European Journal of Immunology · doi:10.1002/eji.201444862 · Cited by 84
The prima donna of epigenetics: the regulation of gene expression by DNA methylation
Santos, K. F., Mazzola, T. N., & Carvalho, H. F. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005001000010 · Cited by 79
Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine
Spagnolo, P., & Cottin, V. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103973 · Cited by 82
Chemoprevention by resveratrol and pterostilbene: Targeting on epigenetic regulation
Lee, P., Chiou, Y., Ho, C., & Pan, M. (2017) · BioFactors · doi:10.1002/biof.1401 · Cited by 87
Souto, J. A., Vaz, E., Lepore, I., Pöppler, A., Franci, G., Álvarez, R., Altucci, L., & de Lera, Á. R. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100244y · Cited by 91
Genetic and epigenetic mechanisms and their possible role in abdominal aortic aneurysm
Krishna, S. M., Dear, A. E., Norman, P. E., & Golledge, J. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.02.008 · Cited by 104
Shiraishi, M., & Hayatsu, H. (2004) · DNA Research · doi:10.1093/dnares/11.6.409 · Cited by 94
Spreading Chromatin into Chemical Biology
Allis, C. D., & Muir, T. W. (2011) · ChemBioChem · doi:10.1002/cbic.201000761 · Cited by 84
Huang, W., Xiong, J., Yang, Y., Liu, S.-M., Yuan, B.-F., & Feng, Y.-Q. (2015) · RSC Advances · doi:10.1039/c5ra05307b · Cited by 77
Prediction of Plant Height in Arabidopsis thaliana Using DNA Methylation Data
Hu, Y., Morota, G., Rosa, G. J. M., & Gianola, D. (2015) · Genetics · doi:10.1534/genetics.115.177204 · Cited by 84
Cherkezyan, L., Stypula‐Cyrus, Y., Subramanian, H., White, C., Cruz, M. D., Wali, R. K., Goldberg, M. J., Bianchi, L. K., Roy, H. K., & Backman, V. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-189 · Cited by 86
Inhibition of histone deacetylase as a new mechanism of teratogenesis
Menegola, E., Renzo, F. D., Broccia, M. L., & Giavini, E. (2006) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20082 · Cited by 88
Ilnytskyy, Y., Zemp, F. J., Koturbash, I., & Kovalchuk, O. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.080 · Cited by 79
EpimiR: a database of curated mutual regulation between miRNAs and epigenetic modifications
Dai, E., Yu, X., Zhang, Y., Meng, F., Wang, S., Liu, X., Liu, D., Wang, J., Li, X., & Jiang, W. (2014) · Database · doi:10.1093/database/bau023 · Cited by 89
TheMTHFR 1298A>CPolymorphism and Genomic DNA Methylation in Human Lymphocytes
Friso, S., Girelli, D., Trabetti, E., Olivieri, O., Guarini, P., Pignatti, P. F., Corrocher, R., & Choi, S. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0601 · Cited by 79
Gourdain, S., Dairou, J., Denhez, C., Bui, L. C., Rodrigues-Lima, F., Janel, N., Delabar, J. M., Cariou, K., & Dodd, R. H. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401049v · Cited by 70
Chung, S. A., Nititham, J., Elboudwarej, E., Quach, H., Taylor, K. E., Barcellos, L. F., & Criswell, L. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129813 · Cited by 83
Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
Liu, F., Mischel, P. S., & Cavenee, W. K. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0005-2 · Cited by 80
DeepDiff: DEEP-learning for predicting DIFFerential gene expression from histone modifications
Sekhon, A., Singh, R., & Qi, Y. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty612 · Cited by 77
Vineis, P., Khan, A. E., Vlaanderen, J., & Vermeulen, R. (2009) · Environmental Health · doi:10.1186/1476-069x-8-54 · Cited by 74
DNA methylation biomarker candidates for early detection of colon cancer
Yi, J. M., Dhir, M., Guzzetta, A. A., Iacobuzio–Donahue, C. A., Heo, K., Yang, K., Suzuki, H., Toyota, M., Kim, H.-M., & Ahuja, N. (2012) · Tumor Biology · doi:10.1007/s13277-011-0302-2 · Cited by 83
Chatterjee, J., Rechenmacher, F., & Kessler, H. (2012) · Angewandte Chemie · doi:10.1002/ange.201205674 · Cited by 80
Epigenetics and transgenerational inheritance in domesticated farm animals
Feeney, A., Nilsson, E. E., & Skinner, M. K. (2014) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/2049-1891-5-48 · Cited by 87
Dimitriou, N. M., Tsekenis, G., Balanikas, E., Pavlopoulou, A., Mitsiogianni, M., Mantso, T., Pashos, G., Boudouvis, A. G., Lykakis, I. N., Tsigaridas, G., et al. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.006 · Cited by 79
PET neuroimaging reveals histone deacetylase dysregulation in schizophrenia
Gilbert, T. M., Zürcher, N. R., Wu, C. J., Bhanot, A., Hightower, B. G., Kim, M., Albrecht, D., Wey, H., Schroeder, F. A., Rodriguez-Thompson, A., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci123743 · Cited by 82
Zinc-dependent Deacetylase (HDAC) Inhibitors with Different Zinc Binding Groups
Li, Y., Wang, F., Chen, X., Wang, J., Zhao, Y., Li, Y., & He, B. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190122144949 · Cited by 80
Asymmetrical methyltransferase PRMT3 regulates human mesenchymal stem cell osteogenesis via miR-3648
Zhang, M., Xiaomeng, L., Li, Z., Du, Y., Xuejiao, L., Lv, L., Xiao, Z., Yunsong, L., Ping, Z., & Zhou, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1815-7 · Cited by 79
Garcinol—A Natural Histone Acetyltransferase Inhibitor and New Anti-Cancer Epigenetic Drug
Kopytko, P., Piotrowska, K., Janisiak, J., & Tarnowski, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062828 · Cited by 74
Candelaria, M., Herrera, A., Labardini, J., González‐Fierro, A., Trejo‐Becerril, C., Taja‐Chayeb, L., Pérez‐Cárdenas, E., la Cruz-Hernández, E. N. D., Arias-Bofill, D., Vidal, S., et al. (2010) · Annals of Hematology · doi:10.1007/s00277-010-1090-2 · Cited by 84
The multiple layers of non-genetic regulation of PTEN tumour suppressor activity
Correia, N., Gírio, A., Antunes, I., Martins, L. R., & Barata, J. T. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.08.017 · Cited by 84
Keynote review: Chromatin control and cancer-drug discovery: realizing the promise
Inche, A. G., & Thangue, N. B. L. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03691-3 · Cited by 90
Expression profiling of DNA methylation-mediated epigenetic gene-silencing factors in breast cancer
Kar, S., Sengupta, D., Deb, M., Shilpi, A., Parbin, S., Rath, S. K., Pradhan, N., Rakshit, M., & Patra, S. K. (2014) · Clinical Epigenetics · doi:10.1186/1868-7083-6-20 · Cited by 79
Epigenetic Mechanism Involved in the HBV/HCV-Related Hepatocellular Carcinoma Tumorigenesis
Liang, R., Huang, N., Li, Z., Ji, F., & Shiwen, J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990533 · Cited by 79
Cheng, S., Xie, M., Chen, Y., Xiong, J., Liu, Y., Chen, Z., Guo, S., Shu, Y., Wang, M., Yuan, B., et al. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00905 · Cited by 78
Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734
Spriano, F., Gaudio, E., Cascione, L., Tarantelli, C., Melle, F., Motta, G., Priebe, V., Rinaldi, A., Golino, G., Mensah, A. A., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001879 · Cited by 79
Metabolic syndrome components are associated with DNA hypomethylation
Luttmer, R., Spijkerman, A. M. W., Kok, R. M., Jakobs, C., Blom, H. J., Serné, E. H., Dekker, J. M., & Smulders, Y. M. (2012) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.06.001 · Cited by 87
The Human Cancer Genome Project—one more misstep in the war on cancer
Miklos, G. L. G. (2005) · Nature Biotechnology · doi:10.1038/nbt0505-535 · Cited by 76
D’Addario, C., Caputi, F. F., Ekström, T. J., Benedetto, M. D., Maccarrone, M., Romualdi, P., & Candeletti, S. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9829-y · Cited by 78
Hassler, M. R., Pulverer, W., Lakshminarasimhan, R., Redl, E., Hacker, J., Garland, G. D., Merkel, O., Schiefer, A., Simonitsch‐Klupp, I., Kenner, L., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.018 · Cited by 82
Self-citationEpigenetic targeting drugs potentiate chemotherapeutic effects in solid tumor therapy
Li, J., Hao, D., Wang, L., Wang, H., Wang, Y., Zhao, Z., Li, P., Deng, C., & Di, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-04406-0 · Cited by 81
MicroRNA Regulation of Epigenetic Modifiers in Breast Cancer
Humphries, B. A., Wang, Z., & Yang, C. (2019) · Cancers · doi:10.3390/cancers11070897 · Cited by 82
HDAC 6 at the Intersection of Neuroprotection and Neurodegeneration
d'Ydewalle, C., Bogaert, E., & Van Den Bosch, L. (2012) · Traffic · doi:10.1111/j.1600-0854.2012.01347.x · Cited by 73
Kim, D., Song, J., Han, J., Kim, Y., Chun, C. H., & Jin, E. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.034 · Cited by 76
Regulatory role of the 90-kDa-heat-shock protein (Hsp90) and associated factors on gene expression
Erlejman, A. G., Lagadari, M., Toneatto, J., Piwien‐Pilipuk, G., & Galigniana, M. D. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.12.006 · Cited by 86
AMPHIBIANS AS MODEL ORGANISMS FOR STUDY ENVIRONMENTAL GENOTOXICITY
Burlibaşa, L. (2011) · Applied Ecology and Environmental Research · doi:10.15666/aeer/0901_001015 · Cited by 85
Cabrero‐Antonino, J. R., Adam, R., Junge, K., & Beller, M. (2016) · Catalysis Science & Technology · doi:10.1039/c6cy01401a · Cited by 75
Rathert, P., Zhang, X., Freund, C., Cheng, X., & Jeltsch, A. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.013 · Cited by 86
Chemical primer extension: efficiently determining single nucleotides in DNA
Hagenbuch, P., Kervio, E., Hochgesand, A., Plutowski, U., & Richert, C. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200501794 · Cited by 74
Hulf, T., Sibbritt, T., Wiklund, E. D., Bert, S. A., Strbenac, D., Statham, A. L., Robinson, M. D., & Clark, S. J. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-54 · Cited by 77
Identifying DNA Methylation Biomarkers of Cancer Drug Response
Maier, S., Dahlstroem, C., Haefliger, C., Plum, A., & Piepenbrock, C. (2005) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200505040-00003 · Cited by 80
An efficient and exact stochastic simulation method to analyze rare events in biochemical systems
Kuwahara, H., & Mura, I. (2008) · The Journal of Chemical Physics · doi:10.1063/1.2987701 · Cited by 92
Nutritional modulation of ageing: Genomic and epigenetic approaches
Mathers, J. C. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.01.018 · Cited by 81
Kung, P., Rui, E. Y., Bergqvist, S., Bingham, P., Braganza, J., Collins, M. R., Cui, M., Diehl, W. C., Dinh, D. M., Fan, C., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00515 · Cited by 75
Ribas, L., Vanezis, K., Imués-Figueroa, M. A., & Piferrer, F. (2017) · Epigenetics & Chromatin · doi:10.1186/s13072-017-0168-7 · Cited by 78
New anti-cancer strategies: Epigenetic therapies and biomarkers
Balch, C. (2005) · Frontiers in bioscience · doi:10.2741/1668 · Cited by 78
Synthetic epigenetics—towards intelligent control of epigenetic states and cell identity
Jurkowski, T. P., Ravichandran, M., & Stepper, P. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0044-x · Cited by 81
Wu, Y., & Xu, Y. (2020) · Cancer Medicine · doi:10.1002/cam4.2899 · Cited by 78
Methylation of tumor associated genes in tissue and plasma samples from liver disease patients
Chang, H., Yi, B., Li, L., Zhang, H., Sun, F., Shu-qiang, D., & Cao, Y. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.07.001 · Cited by 76
Rius, M., Stresemann, C., Keller, D. B., Brom, M., Schirrmacher, E., KEPPLER, D. O. R., & Lyko, F. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0743 · Cited by 73
MicroRNAs and DNA methylation as epigenetic regulators of mitosis, meiosis and spermiogenesis
Yao, C., Liu, Y., Sun, M., Niu, M., Yuan, Q., Hai, Y., Guo, Y., Chen, Z., Hou, J., Liu, Y., et al. (2015) · Reproduction · doi:10.1530/rep-14-0643 · Cited by 88
Tanaka, K., Imoto, I., Inoue, J., Kozaki, K., Tsuda, H., Shimada, Y., Aiko, S., Yoshizumi, Y., Iwai, T., Kawano, T., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210459 · Cited by 73
Knockdown of SMYD3 by RNA interference inhibits cervical carcinoma cell growth and invasion in vitro
Wang, S., Luo, X., Shen, J., Zou, J.-N., Lu, Y.-H., & Xi, T. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.4.294 · Cited by 72
Environmental epigenetics and epigenetic inheritance in domestic farm animals
Thompson, R. P., Nilsson, E. E., & Skinner, M. K. (2020) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2020.106316 · Cited by 83
Lorenzo, P. M., Izquierdo, A. G., Rodríguez-Carnero, G., Fernández‐Pombo, A., Iglesias, A., Carreira, M. C., Pérez, C. T., Bellido, D., Olmos, M. Á. M., Leis, R., et al. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac038 · Cited by 84
Stols‐Gonçalves, D., Mak, A. L., Madsen, M. S. A., van der Vossen, E. W. J., Bruinstroop, E., Henneman, P., Mol, F., Scheithauer, T. P. M., Smits, L. P., Witjes, J. J., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2223330 · Cited by 76
Takeshima, M., Saitoh, M., Kusano, K., Nagayasu, H., Kurashige, Y., Muthumala, M., Arakawa, T., Takuma, T., Chiba, I., Kaku, T., et al. (2008) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2008.00644.x · Cited by 78
Epigenetic Therapy for Solid Tumors: from Bench Science to Clinical Trials
Juo, Y.-Y., Gong, X.-J., Mishra, A., Cui, X. X., Baylin, S. B., Azad, N. S., & Ahuja, N. (2015) · Epigenomics · doi:10.2217/epi.14.73 · Cited by 74
Masterpasqua, F. (2009) · Review of General Psychology · doi:10.1037/a0016301 · Cited by 76
James, P., Sajjadi, S., Tomar, A. S., Saffari, A., Fall, C. H. D., Prentice, A. M., Shrestha, S., Issarapu, P., Yadav, D. K., Kaur, L., et al. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy153 · Cited by 82
Herranz, M., Martín‐Caballero, J., Fraga, M. F., Ruı́z-Cabello, J., Flores, J. M., Desco, M., Márquez, V. E., & Esteller, M. (2005) · Blood · doi:10.1182/blood-2005-05-2033 · Cited by 72
DNA Methylation as a Therapeutic Target for Bladder Cancer
Nunes, S. P., Henrique, R., Jerónimo, C., & Paramio, J. M. (2020) · Cells · doi:10.3390/cells9081850 · Cited by 78
Zhang, W., Barger, C. J., Link, P. A., Mhawech-Fauceglia, P. Y., Miller, A., Akers, S. N., Odunsi, K. O., & Karpf, A. R. (2015) · Epigenetics · doi:10.1080/15592294.2015.1062206 · Cited by 76
Zhu, Q.-Y., Wang, Z., Ji, C., Cheng, L., Yang, Y.-L., Ren, J., Jin, Y.-H., Wang, Q.-J., Gu, X.-J., Bi, Z.-G., et al. (2011) · Cell Death and Disease · doi:10.1038/cddis.2010.96 · Cited by 71
HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells
Wang, Y., Wang, X., Liu, L., & Wang, X. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.037 · Cited by 71
Epigenetic and miRNA Expression Changes in People with Pain: A Systematic Review
Polli, A., Godderis, L., Ghosh, M., Ickmans, K., & Nijs, J. (2019) · Journal of Pain · doi:10.1016/j.jpain.2019.12.002 · Cited by 79
Gopinathan, G., & Khosla, S. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-4525-4_26 · Cited by 75
Role of 5-hydroxymethylcytosine in neurodegeneration
Sherwani, S. I., & Khan, H. A. (2015) · Gene · doi:10.1016/j.gene.2015.06.052 · Cited by 75
Liu, W., Lai, H., Huang, R., Zhao, C., Wang, Y., Weng, X., & Zhou, X. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.02.005 · Cited by 70
Kumagai, C., Kálmán, B., Middleton, F. A., Vyshkina, T., & Massa, P. T. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.03.003 · Cited by 76
Rajavelu, A., Tulyasheva, Z., Jaiswal, R., Jeltsch, A., & Kuhnert, N. (2011) · BMC Biochemistry · doi:10.1186/1471-2091-12-16 · Cited by 74
Epigenetic profiles as defined signatures of xenobiotic exposure
Thomson, J. P., Moggs, J. G., Wolf, C. R., & Meehan, R. R. (2013) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2013.08.007 · Cited by 74
Bae, S., Cheriyath, V., Jacobs, B., Reu, F. J., & Borden, E. C. (2007) · Oncogene · doi:10.1038/sj.onc.1210655 · Cited by 76
Epigenetics and periodontal disease: future perspectives
Gomez, R. S., Dutra, W. O., & Moreira, P. R. (2009) · Inflammation Research · doi:10.1007/s00011-009-0041-7 · Cited by 70
Dobosy, J. R., Fu, V. X., Desotelle, J. A., Srinivasan, R., Kenowski, M. L., Almassi, N., Weindruch, R. H., Svaren, J. P., & Jarrard, D. F. (2008) · The Prostate · doi:10.1002/pros.20782 · Cited by 70
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
Morris, M. R., & Maher, E. R. (2010) · Genome Medicine · doi:10.1186/gm180 · Cited by 79
Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer
Carey, J. P. W., Asirvatham, A. J., Galm, O., Ghogomu, T. A., & Chaudhary, J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-173 · Cited by 80
Mongan, N. P., & Gudas, L. J. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0079 · Cited by 70
Applications of Optical Microcavity Resonators in Analytical Chemistry
Wade, J. H., & Bailey, R. C. (2016) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-071015-041742 · Cited by 79
Golouh, R., Čufer, T., Sadikov, A., Nussdorfer, P., Usher, P. A., Brünner, N., Schmitt, M., Lesche, R., Maier, S., Timmermans, M. A. M., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9724-3 · Cited by 69
Epigenetics and assisted reproductive technologies
Pinborg, A. B., Loft, A., Romundstad, L. B., Wennerholm, U., Söderström‐Anttila, V., Bergh, C., & Aittomäki, K. (2015) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12799 · Cited by 77
Epigenetic Modifications and Therapy in Multiple Sclerosis
Aslani, S., Jafari, N., Javan, M. R., Karami, J., Ahmadi, M., & Jafarnejad, M. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8422-x · Cited by 87
Guhathakurta, S., Bok, E., Evangelista, B., & Kim, Y. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.04.004 · Cited by 74
Wang, Z., Long, H., Chang, C., Zhao, M., & Lu, Q. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2864-2 · Cited by 99
Metadata
- Authors
- Egger, G., Liang, G., Aparicio, A., & Jones, P. A.
- Affiliations
- University of Southern California (US)
- Venue
- Nature
- Published
- 2004-05
- Volume
- 429
- Issue
- 6990
- Pages
- 457-463
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2004172747
- Cited by
- 3,232
- References
- 96
- Citations by year
- 2026: 32 · 2025: 76 · 2024: 100 · 2023: 132 · 2022: 124 · 2021: 175 · 2020: 140 · 2019: 173 · 2018: 185 · 2017: 192 · 2016: 180 · 2015: 208 · 2014: 159 · 2013: 175 · 2012: 153
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Max Kade Foundation
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- epigenetics, epigenetic therapy, DNA methylation, histone modifications, gene silencing, hypomethylating agents, histone deacetylase inhibitors, cancer, chromosomal instability syndromes, intellectual disability
- MeSH terms
- Disease, Genetics, Medical, Humans, Genetic Therapy, DNA Methylation, Gene Silencing, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.